Statistics for Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.
Total visits
| views | |
|---|---|
| Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV. | 100 |
Total visits per month
| views | |
|---|---|
| September 2024 | 8 |
| October 2024 | 16 |
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
File Visits
| views | |
|---|---|
| Annals of Oncology 2016, 27, 267 – 274.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 48 |
| China | 18 |
| Australia | 10 |
| Canada | 5 |
| Portugal | 5 |
| India | 4 |
| Argentina | 2 |
| Hong Kong SAR China | 2 |
| Ukraine | 2 |
| Brazil | 1 |
| Japan | 1 |
| Latvia | 1 |
| Mongolia | 1 |